Editorial Standards

Latest News Today maintains rigorous editorial standards. Our team verifies information from trusted sources and provides context to help readers understand complex stories.

Last Updated: Thursday, October 1, 2026 at 04:34 PM
Category: News

Editor's Note

Latest News Today provides comprehensive coverage and analysis of breaking news stories. This article is part of our ongoing coverage of editorial participation vital fight against sickle cell n595156, bringing you verified information from trusted sources with added context and expert perspective.

Why This Matters: Understanding the full context of this story helps readers make informed decisions and stay updated on developments that impact our community.

Editorial: Participation Vital in Fight Against Sickle Cell

About five times a day, a child with sickle cell disease is born, the vast majority to African-American parents.
Image: Red blood cells in a patient with sickle cell disease
Red blood cells in a patient with sickle cell disease are shown in a June 2014 image provided by the National Institutes of Health.AP

The good news is that science is moving forward. But we cannot achieve success alone. The faster we can find qualified patients for clinical trials, the faster we can potentially bring an exciting new therapy to those who are literally crying out for them.

If you or someone you know is affected by sickle cell disease, use this opportunity to reflect on whether you can get involved in being a part of the solution.

Talk to your doctor about getting involved with a clinical trial to see if you might be able to participate. Together we can lift the burden of disease for these patients. For these patients and their families - every day is “sickle cell day.”

Kevin W. Williams, M.D., J.D., M.P.H. is Chief Medical Officer, Rare Disease at Pfizer, Inc.